| Document Date: 2013-12-23 21:55:01
Open Document File Size: 1,31 MBShare Result on Facebook
City Tokyo / Grosseto / Saniabadi / Edinburgh / Levy / / Company Olsson AG / MC Laboratory Inc. / Hulinks Inc. / Suzuki / / Country Japan / Italy / / / Facility Takashi Hitsumoto Hitsumoto Medical Clinic / Hitsumoto Medical Clinic / / / MedicalCondition insulin resistance / hypertension / acute coronary syndromes / disease / peripheral arterial disease / atherosclerosis / hypertriglyceridemia / stroke / cardiovascular disease / hyperlipidemia / acute coronary syndrome / hyperlipoproteinemia / myocardial infarction / chronic inflammation / deformity / coronary diseases / Methods Introduction Hypercholesterolemia / fatty liver / Inflammation / Hypercholesterolemia / syndrome / inflammatory / / MedicalTreatment drug therapy / / Organization Japanese Society / AA EPA / Environmental Protection Agency / / Person Takashi Hitsumoto Hitsumoto / Arch Med Res / HOMA-IR EPA / / / Position Prime Minister / / Product valsartan / Adenosine / Lovastatin / / ProvinceOrState Rhode Island / Arkansas / /
SocialTag |
Received: Dec 9, 2012 Accepted: Apr. 1, 2013 Published online: Apr. 30, 2013 Original Article